Showing results (191-200 of 324) with videos related to
Sort By:
Pageof 33
Anti-Cancer Drugs|January 12, 2000
Phase II study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimensJ Y Blay, I Judson, S Rodenhuis, et al.Sarcoma|June 4, 2008
Treatment of epithelioid sarcoma at the royal marsden hospitalL Livi, N Shah, F Paiar, et al.International Journal of Radiation Oncology, Biology, Physics|September 1, 1984
A phase I study of the combination of benznidazole and CCNU in manJ T Roberts, N M Bleehen, F Y Lee, et al.Journal of the National Cancer Institute|November 24, 1999
DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90L R Kelland, S Y Sharp, P M Rogers, et al.British Journal of Cancer|September 29, 2004
Characterisation of molecular events following cisplatin treatment of two curable ovarian cancer models: contrasting role for p53 induction and apoptosis in vivoP A Clarke, K E Pestell, F Di Stefano, et al.Journal of the National Cancer Institute|March 6, 1996
Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9S A Fitzsimmons, P Workman, M Grever, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
DT-diaphorase activity correlates with sensitivity to the indoloquinone EO9 in mouse and human colon carcinomasM I Walton, M C Bibby, J A Double, et al.British Journal of Cancer|September 1, 1984
Preclinical pharmacokinetics of benznidazoleP Workman, R A White, M I Walton, et al.British Journal of Cancer|September 17, 2002
Use of radiolabelled choline as a pharmacodynamic marker for the signal transduction inhibitor geldanamycinD Liu, O C Hutchinson, S Osman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Anthrapyrazole CI941: a highly active new agent in the treatment of advanced breast cancerD C Talbot, I E Smith, J L Mansi, et al.Pageof 33